Guest
Open Access Plus
|
Free Content
|
About
|
Sign in
|
New Users: Sign up
|
Mark List
Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents)
ISSN:
1871-5206
eISSN:
1875-5992
< Previous Issue
|
Next Issue >
|
All Issues
|
All Titles
Volume 12
Issue 9
Articles
The Nuclear Orphan Receptors NR4A as Therapeutic Target in Cancer Therapy
pp.1001-1014 (14)
Authors:
Alexander J. A. Deutsch, Hannes Angerer, Tamara E. Fuchs, Peter Neumeister
Colon Adenocarcinoma Multidrug Resistance Reverted by Euphorbia Diterpenes: Structure-Activity Relationships and Pharmacophore Modeling
pp.1015-1024 (10)
Authors:
Mariana Reis, Ricardo J. Ferreira, Julianna Serly, Noelia Duarte, Ana M. Madureira, Daniel J. V. A. Santos, Joseph Molnar, Maria-Jose U. Ferreira
The Role of Peroxisome Proliferator-Activated Receptor-γ in Breast Cancer
pp.1025-1044 (20)
Authors:
Ioly Kotta-Loizou, Constantinos Giaginis, Stamatios Theocharis
CCR5 as a Potential Target in Cancer Therapy: Inhibition or Stimulation?
pp.1045-1057 (13)
Authors:
Alicia Gonzalez-Martin, Emilia Mira, Santos Manes
Doxorubicin-Loaded Nanoparticles: New Advances in Breast Cancer Therapy
pp.1058-1070 (13)
Authors:
Jose Prados, Consolacion Melguizo, Raul Ortiz, Celia Velez, Pablo J. Alvarez, Jose L. Arias, Maria A. Ruiz, Visitacion Gallardo, Antonia Aranega
Anti-metastatic and Anti-angiogenic Properties of Potential New Anti-cancer Drugs Based on Metal Complexes of Selenosemicarbazones
pp.1071-1080 (10)
Authors:
Manja Zec, Tatjana Srdic-Rajic, Aleksandra Konic-Ristic, Tamara Todorovic, Katarina Andjelkovic, Ivana Filipovic-Ljeskovic, Sinisa Radulovic
Targeted Therapy for Advanced Urothelial Cancer of the Bladder: Where Do We Stand?
pp.1081-1087 (7)
Authors:
Zhaowei Zhu, Zhoujun Shen, Chen Xu
Rational Drug Design for Identifying Novel Multi-target Inhibitors for Hepatocellular Carcinoma
pp.1088-1097 (10)
Authors:
Ahmed Temirak, Mona Abdulla, Mahmoud Elhefnawi
JAK2 Inhibitors for Myelofibrosis: Why are They Effective in Patients with and Without JAK2V617F Mutation?
pp.1098-1109 (12)
Authors:
Fabio P. S. Santos, Srdan Verstovsek
Anti-cancer Effects of Curcumin on Head and Neck Cancers
pp.1110-1116 (7)
Authors:
Wei Gao, Jimmy Yu-Wai Chan, William Ignance Wei, Thian-Sze Wong
Methylenedioxy- and Ethylenedioxy-Fused Indolocarbazoles: Potent Human Topoisomerase I Inhibitors and Antitumor Agents
pp.1117-1131 (15)
Authors:
David E. Zembower, Yongping Xie, Ali Koohang, Mary J. Kuffel, Matthew M. Ames, Yasheen Zhou, Rama Mishra, Aye Aye Mar, Michael T. Flavin, Ze-Qi Xu
Dual Roles of Sulforaphane in Cancer Treatment
pp.1132-1142 (11)
Authors:
Tongzhen Xu, Dongmei Ren, Xuefei Sun, Guotao Yang
Selected Approaches for Rational Drug Design and High Throughput Screening to Identify Anti-Cancer Molecules
pp.1143-1155 (13)
Authors:
Michael Hedvat, Luni Emdad, Swadesh K. Das, Keetae Kim, Santanu Dasgupta, Shibu Thomas, Bin Hu, Shan Zhu, Rupesh Dash, Bridget A. Quinn, Regina A. Oyesanya, Timothy P. Kegelman, Upneet K. Sokhi, Siddik Sarkar, Eda Erdogan, Mitchell E. Menezes, Praveen Bhoopathi, Xiang-Yang Wang, Martin G. Pomper, Jun Wei, Bainan Wu, John L. Stebbins, Paul W. Diaz, John C. Reed, Maurizio Pellecchia, Devanand Sarkar, Paul B. Fisher
Key:
New Content
Free Content
Open Access Plus
Subscribed Content
Bentham Science Publishers
www.benthamscience.com
